Ifp Advisors, Inc Cytosorbents Corp Transaction History

Ifp Advisors, Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$1.03 - $2.03 $239 - $472	233 Added 16.02%	1,687 $20,000
Q2 2022 Sep 06, 2022	BUY	$1.76 - $3.22 $2,559 - $4,681	1,454 New	1,454 $17,000
Q2 2022 Aug 12, 2022	SELL	$1.76 - $3.22 $2,559 - $4,681	-1,454 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$2.88 - $4.23 $4,187 - $6,150	1,454 New	1,454 $4,000
Q3 2021 Oct 06, 2021	SELL	$7.0 - $9.71 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$7.55 - $9.42 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	SELL	$8.23 - $11.48 $16,188 - $22,581	-1,967 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$7.37 - $11.54 $14,496 - $22,699	1,967 New	1,967 $16,000
Q2 2020 Aug 05, 2020	BUY	$6.28 - $10.59 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$3.77 - $7.73 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$3.61 - $5.22 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$4.33 - $7.63 $0 - $0	0 New	0 $0
Q4 2018 Jan 23, 2019	SELL	$7.05 - $12.64 $3,031 - $5,435	-430 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$10.95 - $14.8 $4,708 - $6,364	430 New	430 $0
Q4 2017 Jan 24, 2018	SELL	$5.9 - $7.05 $33,040 - $39,480	-5,600 Closed	0 $0
Q2 2016 Jun 03, 2019	BUY	N/A	5,600	5,600 $25,000

16.7M

15.4K

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $42.3M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.